Allahna Esber1, Nisha Rao, Alison Norris, Patricia Carr Reese, Jonathan Kandodo, Patrick Nampandeni, Enock Jumbe, Abigail Norris Turner. 1. From the *Division of Epidemiology, †College of Medicine, The Ohio State University, Columbus, OH; ‡The George Washington University School of Medicine and Health Sciences, Washington, DC; §Child Legacy International, Umoyo wa Thanzi Research, Lilongwe Malawi; and ¶Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University, Columbus, OH.
Abstract
BACKGROUND: Many women engage in intravaginal practices (IVP) with a goal of improving genital hygiene and increasing sexual pleasure. Intravaginal practices can disrupt the genital mucosa, and some studies have found that IVP increases risk of acquisition of HIV and bacterial vaginosis (BV). Limited prior research also suggests significant associations between IVP, herpes simplex virus type 2 (HSV-2), and high-risk types of human papillomavirus (HPV). METHODS: We examined associations between IVP and HPV, BV, and HSV-2 among 200 women in rural Malawi participating in a clinic-based study on sexual and reproductive tract infections. We calculated prevalence ratios for the associations between frequency and type of IVP and outcomes of HPV, BV, and HSV-2. RESULTS: Intravaginal practices were commonly performed, with 95% of women reporting current use of at least 1 practice. Infections were also frequently detected: Twenty-two percent of the sample had at least 1 high-risk HPV type, 51% had BV, and 50% were HSV-2 seropositive. We observed no significant associations between type of IVP, frequency of IVP, or a combined measure capturing type and frequency of IVP-and any of the infection outcomes. CONCLUSIONS: Although both IVP and our outcomes of interest (BV, HPV, and HSV-2) were common in the study population, we did not detect associations between IVP type or frequency and any of the 3 infections. However, the high prevalence and frequency of IVP may have limited our ability to detect significant associations.
BACKGROUND: Many women engage in intravaginal practices (IVP) with a goal of improving genital hygiene and increasing sexual pleasure. Intravaginal practices can disrupt the genital mucosa, and some studies have found that IVP increases risk of acquisition of HIV and bacterial vaginosis (BV). Limited prior research also suggests significant associations between IVP, herpes simplex virus type 2 (HSV-2), and high-risk types of human papillomavirus (HPV). METHODS: We examined associations between IVP and HPV, BV, and HSV-2 among 200 women in rural Malawi participating in a clinic-based study on sexual and reproductive tract infections. We calculated prevalence ratios for the associations between frequency and type of IVP and outcomes of HPV, BV, and HSV-2. RESULTS: Intravaginal practices were commonly performed, with 95% of women reporting current use of at least 1 practice. Infections were also frequently detected: Twenty-two percent of the sample had at least 1 high-risk HPV type, 51% had BV, and 50% were HSV-2 seropositive. We observed no significant associations between type of IVP, frequency of IVP, or a combined measure capturing type and frequency of IVP-and any of the infection outcomes. CONCLUSIONS: Although both IVP and our outcomes of interest (BV, HPV, and HSV-2) were common in the study population, we did not detect associations between IVP type or frequency and any of the 3 infections. However, the high prevalence and frequency of IVP may have limited our ability to detect significant associations.
Authors: Andrea Low; Marie-Noelle Didelot-Rousseau; Nicolas Nagot; Abdoulaye Ouedraougo; Tim Clayton; Issouf Konate; Philippe Van de Perre; Michel Segondy; Philippe Mayaud Journal: Sex Transm Infect Date: 2010-04-21 Impact factor: 3.519
Authors: Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley Journal: J Infect Dis Date: 2006-04-26 Impact factor: 5.226
Authors: P G Motti; G A Dallabetta; R W Daniel; J K Canner; J D Chiphangwi; G N Liomba; L Yang; K V Shah Journal: J Infect Dis Date: 1996-03 Impact factor: 5.226
Authors: R Kaul; C Pettengell; P M Sheth; S Sunderji; A Biringer; K MacDonald; S Walmsley; A Rebbapragada Journal: J Reprod Immunol Date: 2007-03-28 Impact factor: 4.054
Authors: Deborah Watson-Jones; Helen A Weiss; Mary Rusizoka; Kathy Baisley; Kokugonza Mugeye; John Changalucha; Dean Everett; Rebecca Balira; Louise Knight; David Ross; Richard J Hayes Journal: J Acquir Immune Defic Syndr Date: 2007-12-15 Impact factor: 3.731
Authors: Christine Tagliaferri Rael; Doyel Das; Jose Bauermeister; Cody Lentz; Alex Carballo-Diéguez; Rebecca Giguere; Rachel K Scott; Craig W Hendrix Journal: AIDS Behav Date: 2021-05-12
Authors: Sibylle Gerstl; Lawrence Lee; Robin C Nesbitt; Christopher Mambula; Hartini Sugianto; Twambilire Phiri; James Kachingwe; Augusto Eduardo Llosa Journal: BMC Public Health Date: 2022-02-14 Impact factor: 3.295